Richard Francis Intended to be Appointed Purespring Therapeutics CEO Following Completion of Its Series A Financing of £45.0 Mil, from 1 February 2021
Richard is a leading pharmaceutical executive with over 25 years’ experience in building sustainable, world-class life science companies. He most recently held the role of Chief Executive Officer of Sandoz, a division of Novartis. Sandoz is a global leader in generic pharmaceuticals and biosimilars.
Atriomx Health Announces $10 Million Series A Financing-Funds to Be Used for Development and Clinical Study
"This financing will allow Atriomx to pursue the tremendous opportunity to transform the diagnosis and treatment of atrial fibrillation stemming from the application of novel AF detection and characterization capabilities to data that can be collected non-invasively," said Duke Rohlen, CEO of Ajax Health and Zeus Health.